We found that baseline NfL concentration was higher in CN+, aMCI, and AD groups compared to the CN- group, reinforcing the potential of NfL as a valuable biomarker for improving diagnostic and prognostic accuracy in AD patients. The gene discussed is NEFL; the disease is Alzheimer disease.